---
schema_version: "secwatch.filing_event.v1"
accession: "0001809519-24-000147"
form_type: "8-K"
ticker: "GDRX"
cik: "0001809519"
company_name: "GoodRx Holdings, Inc."
filed_at: "2024-07-11T23:59:59+00:00"
generated_at: "2026-05-31T21:57:08.678510+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# GoodRx enters Sixth Amendment to Credit Agreement, refinances $500M term loan facility

## Summary
- New $500M 2024 Term Loan Facility matures July 2029 with SOFR + 3.75% margin, used to repay Existing Term Loans ($167.2M cash added).
- Maturity of $88M of $100M revolving credit facility extended to April 2029; remaining $12M terminates July 2025.
- Quarterly principal payments of 0.25% of original principal beginning Q2 2024, prepayment premium 1.00% if before Jan 2025.
- Financial covenant requires First Lien Net Leverage Ratio not exceeding 8.2x if revolving borrowings exceed threshold.

## SEC filing metadata
- accession: 0001809519-24-000147
- form_type: 8-K
- ticker: GDRX
- cik: 0001809519
- company_name: GoodRx Holdings, Inc.
- filed_at: 2024-07-11T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1809519/000180951924000147/0001809519-24-000147-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1809519/000180951924000147/gdrx-20240710.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001809519-24-000147
- JSON: https://secwatch.observer/filing/0001809519-24-000147.json
- Plain text: https://secwatch.observer/filing/0001809519-24-000147.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.